UBA1 and proximal spinal muscular atrophy: This suggests that therapies restoring UBA1, which lead to widespread rescue of SMA phenotypes (Powis et al., 2016), are likely to be modulating numerous, tissue-specific downstream pathways of UBA1, thereby revealing a complex spatiotemporal influence of ubiquitin pathways on disease pathogenesis in SMA and related conditions.